Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
The Journal of Clinical Dentistry|January 1, 1992
Comparative plaque removal efficacy of three toothbrushes in two independent clinical studiesN C Sharma, J Galustians, K N Rustogi, et al.Ground Water|October 3, 2012
Coliform bacteria in New Jersey domestic wells: influence of geology, laboratory, and methodThomas B Atherholt, Raymond T Bousenberry, Gail P Carter, et al.Bioinformatics (Oxford, England)|January 4, 2024
ExEmPLAR (Extracting, Exploring, and Embedding Pathways Leading to Actionable Research): a user-friendly interface for knowledge graph miningJon-Michael T Beasley, Daniel R Korn, Nyssa N Tucker, et al.AJNR. American Journal of Neuroradiology|November 25, 2017
Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MSR Zivadinov, N Bergsland, J R Korn, et al.Current Medical Research and Opinion|April 13, 2018
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) studyRobert Zivadinov, Nasreen Khan, Jonathan R Korn, et al.Journal of Medical Economics|April 24, 2014
Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritisJeffrey R Curtis, Vernon F Schabert, Jason Yeaw, et al.Current Medical Research and Opinion|September 25, 2013
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysisNiklas Bergvall, Charles Makin, Raquel Lahoz, et al.Journal of Medical Economics|July 15, 2014
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysisNiklas Bergvall, Allison A Petrilla, Swapna U Karkare, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|August 2, 2022
PreS/MD: Predictor of Sensitization Hazard for Chemical Substances Released From Medical DevicesVinicius M Alves, Joyce V B Borba, Rodolpho C Braga, et al.CA: a Cancer Journal for Clinicians|June 17, 2023
Social determinants of health and US cancer screening interventions: A systematic reviewAriella R Korn, Callie Walsh-Bailey, Margarita Correa-Mendez, et al.Pageof 11